Skip to content
InMed-logo-01
  • Science
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • IntegraSyn™ Cannabinoid Manufacturing
    • InMed’s Research of Rare Cannabinoids
  • Investor
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • Partners and Collaborators
    • Events Calendar
    • Careers
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
  • Contact
Menu
  • Science
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • IntegraSyn™ Cannabinoid Manufacturing
    • InMed’s Research of Rare Cannabinoids
  • Investor
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • Partners and Collaborators
    • Events Calendar
    • Careers
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
  • Contact
TSX_Logo
NASDAQ_Logo

InMed Conferences and Events

H. C. Wainwright BioConnect 2021

InMed CEO Eric A. Adams to present at H. C. Wainwright BioConnect 2021.

Date: January 11-14, 2021

Conference Website: www.hcwevents.com/bioconnect.

Presentation Details: The company presentation by Eric A. Adams, President and CEO of InMed, will be available on demand beginning January 11th at 6am EST and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event. Presentation Link: https://journey.ct.events/view/a48c3f9e-1802-4279-95ca-eff84fafe024

BIO Partnering at JPM

InMed Pharmaceuticals participating in 1×1 meetings at BIO Partnering at JPM.

Date: January 11-15, 2021

Conference Website: https://www.bio.org/events/bio-partnering-jpm/

For 1×1 meetings, please reach out to [email protected].

Edison Open House: Global Conference 2021

Date: January 26-28, 2021

Conference website: https://www.edisongroup.com/event/open-house-global-healthcare-2021/

Presentation details:  Presentation information will be made available closer to the event.

For 1×1 meetings, please reach out to [email protected].


INM-755

A cannabinol (CBN) cream under development for the treatment for Epidermolysis Bullosa
Learn More

INM-088

For the Treatment of Glaucoma
Learn More
InMed-logo-mono
#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4
Science
  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • IntegraSyn™ Cannabinoid Manufacturing
  • InMed’s Research of Rare Cannabinoids

Investor

  • News Releases
  • Latest Presentation
  • Letter to Shareholders
  • SEDAR® Filings
  • Financial Reports
  • Sign up for Investor Alerts

About

  • Management
  • Board of Directors
  • Scientific Advisory Board
  • Corporate Governance
  • Partners and Collaborators
  • Events Calendar
  • Careers

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2021 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On: